SCHEMBL23611535

SCHEMBL23611535

CC(C)Oc1ccc(-c2ncc(CNc3cc(-c4cn[nH]c4)nc(C(F)(F)F)c3)s2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ KCNH2 Q12809 1/20 0.41
▸ MAPT P10636 7/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TP53 P04637 3/20 0.36
▸ ROCK1 Q13464 1/20 0.35
▸ MYLK4 Q86YV6 1/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ PTGDR Q13258 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30060450 1.00 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23627693 0.88 CYP2C19 (0.43) CYP2C19CYP2C9KCNH2TP53S1PR1
SCHEMBL30060458 0.86 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23611317 0.86 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL31694534 0.85 CYP2C19 (0.53) CYP2C19CYP2C9KCNH2TP53S1PR1
SCHEMBL23611318 0.85 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL30062377 0.85 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23611234 0.85 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL30062257 0.85 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23611330 0.84 MAPT (0.43) CYP2C19CYP2C9MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback